Linezolid and serotonin syndrome

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 6, 2009, Pages 353-356

  Quinn, Davin K ^a   Stern, Theodore A ^b  

^a UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; SEROTONIN 2A AGONIST; SEROTONIN UPTAKE INHIBITOR;

ADVERSE OUTCOME; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; HOSPITAL INFECTION; HUMAN; LABORATORY DIAGNOSIS; PATIENT MONITORING; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEROTONIN BLOOD LEVEL; SEROTONIN BRAIN LEVEL; SEROTONIN SYNDROME; TREATMENT INDICATION;

EID: 77957680315     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.09r00853     Document Type: Article

References (21)

1. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138(2):135-142.
2. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148(6): 705-713.
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 352(11):1112-1120.
4. Taylor JJ, Wilson JW, Estes LL. Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis. 2006;43(2): 180-187.
5. Gillman PK. The serotonin system and its treatment. J Psychopharmacol.1999;13(1):100-109.
6. Rubinstein E, Isturiz R, Standiford HC, et al. Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies. Antimicrob Agents Chemother. 2003;47(6):1824-1831.
7. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006;42(11):1578-1583.
8. Wigen CL, Goetz MB. Serotonin syndrome and linezolid. Clin Infect Dis. 2002;34(12):1651-1652.
9. Thomas CR, Rosenberg M, Blythe V, et al. Serotonin syndrome and linezolid. J Am Acad Child Adolesc Psychiatry. 2004;43(7):790.
10. DeBellis RJ, Schaefer OP, Liquori M, et al. Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient. J Intensive Care Med. 2005;20(6):351-353.
11. Jones SL, Athan E, O'Brien D. Serotonin syndrome due to co-administration of linezolid and venlafaxine. J Antimicrob Chemother. 2004;54(1):289-290.
12. Bergeron L, Boulé M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother. 2005;39(5):956-961.
13. Bernard L, Stern R, Lew D, et al. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis. 2003;37(9): 1274-1275.
14. Tahir N. Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram. J Am Med Dir Assoc. 2004;5(2):111-113.
15. Hachem RY, Hicks K, Huen A, et al. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis. 2003;37(1):e8-e11.
16. Lavery S, Ravi H, McDaniel WW, et al. Linezolid and serotonin syndrome. Psychosomatics. 2001;42(5):432-434.
17. Morales N, Vermette H. Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine. Psychosomatics. 2005; 46(3):274-275.
18. Taylor JJ, Estes LL, Wilson JW. Linezolid and serotonergic drug interactions. Clin Infect Dis. 2006;43(2):180-187.
19. Clark DB, Andrus MR, Byrd DC. Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature. Pharmacotherapy. 2006;26(2):269-276.
20. Steinberg M, Morin AK. Mild serotonin syndrome associated with concurrent linezolid and fluoxetine. Am J Health Syst Pharm. 2007;64(1): 59-62.
21. Strouse TB, Kerrihard TN, Forscher CA, et al. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine. J Clin Psychopharmacol. 2006;26(6):681-683.